Clinical trial
An Randomized Controlled Trial of IMS-treatment Versus Scam for Canalis Carpi Syndrome
NCT01102868 is registered in ClinicalTrials.gov with NORCE Norwegian Research Centre AS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Randomized Controlled Trial of IMS-treatment Versus Scam for Canalis Carpi Syndrome
- Lead sponsor
- NORCE Norwegian Research Centre AS
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- January 31, 2012
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.